Today: 25 January 2026
Subscribe
Browse Category

NASDAQ:JOBY News 9 January 2026 - 11 January 2026

Joby Aviation stock: Jan. 15 Ohio factory deadline and CPI could shake JOBY next week

Joby Aviation stock: Jan. 15 Ohio factory deadline and CPI could shake JOBY next week

NEW YORK, Jan 11, 2026, 05:01 EST — Market closed. Joby Aviation shares enter Monday facing a Jan. 15 deadline to finalize its $61.5 million Ohio factory purchase, following a roughly 0.9% gain on Friday that pushed the stock to $15.39. U.S. markets remain closed over the weekend. The electric air-taxi maker has moved like a high-beta growth stock, swinging…
11 January 2026
····
Archer Aviation stock pops in premarket after Nvidia IGX Thor AI tie-up — here’s what’s next

Archer Aviation stock pops in premarket after Nvidia IGX Thor AI tie-up — here’s what’s next

New York, Jan 9, 2026, 08:08 EST — Premarket Archer Aviation Inc shares were up 2.6% at $8.94 in premarket trading on Friday after the company unveiled an AI collaboration with Nvidia at the CES technology show in Las Vegas. The stock ended Thursday up 3.4% at $8.71, after trading between $8.44 and $9.01 on volume of about 50 million…
9 January 2026
·········

Stock Market Today

  • Is Elevance Health (ELV) Stock Undervalued After Mixed Multi-Year Returns?
    January 24, 2026, 10:24 PM EST. Elevance Health (ELV), a major U.S. health benefits provider, has shown mixed stock performance: a 5.7% decline over one year and a 21.2% drop over three years, but a 33.7% gain over five years. Despite a recent share price of $371.06, a Discounted Cash Flow (DCF) model estimates an intrinsic value of about $1,011.50, suggesting the stock trades at a 63.3% discount. The DCF analysis projects free cash flow rising from $3.58 billion last year to $8.98 billion by 2030, signaling potential undervaluation. This valuation discrepancy may reflect investor caution influenced by ongoing healthcare sector debates, particularly around costs and insurer stability. Simply Wall St rates the stock's valuation 5 out of 6, underscoring a complex picture for investors evaluating ELV's future prospects and current pricing.
Go toTop